Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Comment by ybhere01on Apr 05, 2019 6:06pm
148 Views
Post# 29590360

RE:UGH ....

RE:UGH ....
keeniinvestor wrote:
more options ... 6.1M @ $0.13



Lets not forget, that's nothing compared to the what management have already paid themselves in stock based compensation.

From there own filing: (On SEDAR filing date 29 Aug 2018)
[d] Stock-based compensation
For the three and nine-month periods ended June 30, 2018, the stock-based compensation expense included in net loss, was $8,504,625 and $12,404,746 respectively
 


<< Previous
Bullboard Posts
Next >>